Arkan Ventures has announced a Digital Health Roundtable Series designed to create a structured forum for investors, practitioners, and innovators to examine the evolving role of technology in healthcare delivery and financing. The series aims to convene family offices, digital health operators, thematic specialists, and ESG-aligned allocators for facilitated discussions on capital deployment, sector trends, and the structural conditions shaping care at scale.
The initiative, currently in development with the first sessions anticipated for later in 2026, will ground each convening in Environmental, Social, and Governance (ESG) frameworks. These discussions will be explicitly aligned with the United Nations Sustainable Development Goals, specifically SDG 3 (Good Health and Well-being), SDG 9 (Industry, Innovation and Infrastructure), and SDG 17 (Partnerships for the Goals). Arkan Ventures has stated that all thematic sessions will be mapped to relevant SDG indicators to ensure dialogue remains anchored to measurable outcomes rather than broad aspiration.
This news is significant as it addresses a critical gap in the investment landscape. Chris Marcoux, Chief Communications Officer at Arkan Ventures, explained the rationale behind the series: "The initiative reflects a broader recognition that family offices and impact-aligned investors frequently lack structured access to curated deal flow and peer-level dialogue in the digital health space. We want to increase the space for this kind of dialogue so that digital health technology can be more widely understood." The roundtables could potentially channel more informed capital into a sector crucial for modernizing global healthcare infrastructure.
The potential thematic sessions under consideration highlight the series' focus on pressing industry challenges. These include AI-assisted diagnostics and care delivery, interoperable health data and infrastructure, and the financing of equitable telehealth access in underserved communities. By bringing together diverse stakeholders—including the digital health founders, healthcare investors, and subject-matter experts like clinicians and policy practitioners the firm is currently inviting to contribute—the series seeks to shape actionable agendas that bridge investment strategy with tangible health outcomes.
The impact of this structured dialogue extends beyond individual investment decisions. Participants will engage with ESG measurement methodologies aligned to the SDG Impact Standards, providing a consistent framework to assess healthcare allocations for both financial and social performance. This focus on measurable impact is crucial for scaling technologies that promise to improve care delivery and access. The half-day sessions, which will combine keynote perspectives with facilitated investment dialogue, are designed to be invitation-based and thematically focused, aiming for depth over breadth.
For the healthcare industry and patients worldwide, the development of such a forum signals a maturation in how technology adoption is financed and evaluated. If successful, the roundtable series could help align capital with innovations that not only generate returns but also demonstrably advance public health goals, making tech-enabled care more effective and equitable. The final session dates and topics will be confirmed as the program develops throughout the coming year.
